Showing results (31-40 of 144) with videos related to
Sort By:
Pageof 15
Current Diabetes Reports|May 24, 2003
Heart disease in diabetic patientsMihaela C Blendea, Samy I McFarlane, Esma R Isenovic, et al.Biomedicines|November 26, 2022
Role of Chemerin in Cardiovascular DiseasesMirjana T Macvanin, Manfredi Rizzo, Jelena Radovanovic, et al.Angiology|December 12, 2013
Estradiol in vivo induces changes in cardiomyocytes size in obese ratsMilan Obradovic, Emina Sudar, Sonja Zafirovic, et al.Frontiers in Endocrinology|March 23, 2023
Diabetic cardiomyopathy: The role of microRNAs and long non-coding RNAsMirjana T Macvanin, Zoran Gluvic, Jelena Radovanovic, et al.Nutrients|March 20, 2013
Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approachesDragana Nikolic, Niki Katsiki, Giuseppe Montalto, et al.Frontiers in Endocrinology|January 23, 2023
The protective role of nutritional antioxidants against oxidative stress in thyroid disordersMirjana T Macvanin, Zoran Gluvic, Sonja Zafirovic, et al.Current Medicinal Chemistry|September 5, 2019
Endothelial Dysfunction in Dyslipidaemia: Molecular Mechanisms and Clinical ImplicationsBozidarka Zaric, Milan Obradovic, Andreja Trpkovic, et al.Current Vascular Pharmacology|June 3, 2009
Diabetes and antioxidants: myth or reality?Mohamed A Haidara, Hanaa Z Yassin, Zorica Zakula, et al.Current Vascular Pharmacology|January 7, 2017
Should We be Concerned About the Inflammatory Response to Endovascular Procedures?Djordje Radak, Nenad Djukic, Slobodan Tanaskovic, et al.Frontiers in Endocrinology|March 17, 2023
The Na<sup>+</sup>/K<sup>+</sup>-ATPase: A potential therapeutic target in cardiometabolic diseasesMilan Obradovic, Emina Sudar-Milovanovic, Zoran Gluvic, et al.Pageof 15